e14
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 26, No 1, January/February 2015
AFRICA
Case Report
Takayasu arteritis in pregnancy
Priya Soma-Pillay, Adekunle Adeyemo, Farhana Ebrahim Suleman
Case report
Abstract
Takayasu arteritis is a chronic, granulomatous arteritis affecting large and medium-sized arteries. During pregnancy,
maternal and foetal complications are largely as a consequence of maternal arterial hypertension. We present a case
of a 35-year-old para one gravida two patient with Takayasu
arteritis (group III disease) complicated by chronic hypertension and a severely dilated ascending aorta. Good blood
pressure control during pregnancy is an important measure
in reducing obstetric morbidity.
Keywords: Takayasu arteritis, pregnancy, hypertension, preeclampsia
Submitted 18/9/14, accepted 10/1/15
Published online 5/2/15
Cardiovasc J Afr 2015; 26: e14–e16
www.cvja.co.za
DOI: 10.5830/CVJA-2015-003
Takayasu arteritis is a chronic granulomatous arteritis affecting
large and medium-sized arteries. The disease is characterised
by inflammation of the blood vessels, resulting in destruction
and distortion of the layered components of their walls. During
the early stages of the disease, there are mononuclear cell
infiltrations in the adventitia and granulomas with Langerhans
cells in the media. This is followed by disruption of the elastin
layer and subsequent massive medial and intimal fibrosis. These
lesions result in segmental stenosis, occlusion, dilatation and
aneurysmal formation in the affected vessels.1
Stenotic lesions predominate and have been reported in 90%
of cases, while aneurysms are only reported in approximately
25%.2 This is a disease of young adults with a peak onset in the
second and third decades of life. A case series reported from
South Africa of Takayasu arteritis in childhood demonstrated
a 2:1 female-to-male ratio.3 Patients with Takayasu arteritis may
present with a variety of clinical manifestations, but arterial
hypertension is the most common feature of the disease.4
Cardiac-Obstetric Unit, Steve Biko Academic Hospital,
University of Pretoria, Pretoria, South Africa
Priya Soma-Pillay, priya.somapillay@up.ac.za, FCOG, Cert
(Maternal and Foetal Med) SA
Adekunle Adeyemo, MB BS, MCFP (SA), FCP (SA), Cert Cardiol (SA)
Department of Radiology, Steve Biko Academic Hospital,
University of Pretoria, South Africa
Farhana Ebrahim Suleman, FCRad (D), MMed Rad (D)
A 35-year-old para one gravida two patient, with a previous
uncomplicated full-term delivery at the age of 16 years, was
referred to the cardiac-obstetric unit at eight weeks’ gestation.
She had been diagnosed with Takayasu arteritis six years earlier,
and tuberculosis two years previously, for which she was treated.
She was hypertensive and her blood pressure was controlled with
nifedipine, carvedilol and hydrochlorothiazide. The Takayasu
disease was being treated with prednisone and azathioprine.
Further history revealed that her ascending aorta was dilated,
and on evaluation by cardiothoracic surgeons, the lesion was
considered to be inoperable. The patient was not using any
contraception and this was a planned and wanted pregnancy.
She had no other medical or surgical history of note.
On examination, the patient was apyrexial with a blood
pressure of 120/70 mmHg in both arms and a pulse of 88 beats
per minute. Cardiac examination revealed normal first and
second heart sounds. No third or fourth heart sounds were
heard and there was a one-quarter aortic regurgitation murmur.
Respiratory and abdominal examinations were normal.
Ultrasound examination confirmed an intra-uterine
pregnancy of eight weeks’ gestation. The electrocardiogram
was normal. On echocardiography, the patient had good left
ventricular systolic function with no regional wall-motion
abnormality. There was a tricuspid aortic valve with trivial
aortic regurgitation. The ascending aorta was markedly dilated,
measuring 5.7 cm. No dissection flap was seen.
The descending aorta and its branches had been evaluated by
CT angiography two months prior to pregnancy. The ascending,
arch and descending thoracic aorta were dilated (Fig. 1A, B) with
marked mural thickening of the thoracic (2.3 cm) aorta (Fig. 2A,
B). A laminated thrombus was found on the descending aorta.
The renal arteries were patent. No abnormality was detected on
fundoscopy.
Laboratory findings showed an elevated erythrocyte
sedimentation rate of 56 mm/h and a C-reactive protein level of
9 mg/dl. The full blood count, renal function, electrolytes and
urinalysis were normal.
The patient was managed by a multidisciplinary team of
cardiologists, obstetricians and rheumatologists. After the initial
investigations were performed, the patient was counselled about
the aortic lesions. She was informed about the possibility of
further dilatation or rupture of the aorta during pregnancy.
The patient was offered a termination of pregnancy for medical
reasons, which she declined.
The pregnancy was managed further by the multidisciplinary
team and the patient was treated with prednisone (10 mg
daily) and azathioprine (150 mg alternating with 200 mg daily)
for Takayasu disease, methyl-dopa for hypertension, aspirin
AFRICA
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 26, No 1, January/February 2015
A
e15
B
Fig. 1. Axial CT post-contrast images in the arterial phase demonstrating aneursymal dilatation of the arch of the aorta (A) and the
ascending and descending aorta (B). Note the turbulent flow in the descending aorta.
and calcium gluconate for prevention of pre-eclampsia, and
therapeutic enoxaparin for the thrombus in the descending aorta.
First-trimester foetal aneuploidy screening was negative and
the foetus was also structurally normal. The patient was seen
every two weeks at the cardiac-obstetric unit for evaluation of
blood pressure, urinalysis and foetal growth. An echocardiogram
was done monthly to evaluate the aorta for disease progression.
The antenatal course was uneventful. The blood pressure was
well controlled (around 130/70 mmHg) with appropriate foetal
growth. The patient was delivered by elective caesarean section
with spinal anaesthesia at 34 weeks’ gestation. A healthy baby
weighing 2.3 kg with good Apgars was delivered. The mother
was observed in a high-dependency unit for 24 hours after
delivery where her blood pressure remained well controlled.
After delivery, treatment with prednisone, azathioprine and
enoxaparin was continued, methyl-dopa was stopped and
nifedipine re-started and stool-softeners were also prescribed.
The patient was discharged five days after delivery. Repeat CT
angiography and echocardiogram at the six-week postnatal visit
was unchanged.
A
Discussion
Takayasu arteritis was first described in 1908 by the Japanese
ophthalmologist who observed retinopathy in the absence of
peripheral pulses. Autoimmunity, sex hormones (more common
in females) and a genetic predisposition of the human leucocyte
antigen have been proposed as possible causes.5
The disease is classified clinically into stages depending on
the presence of complications such as hypertension, retinopathy,
aneurysms and aortic insufficiency: group I, uncomplicated
disease; group IIa, single complication with uncomplicated
disease; group IIb, severe single complication with uncomplicated
disease; group III, two or more complications with uncomplicated
disease.6 Our patient had group III disease.
Patients with Takayasu disease should be managed in a highrisk obstetric unit. Pregnancy is not associated with disease
progression, however there is a 60% risk of complications
developing during pregnancy.7 Maternal risks are attributed
mainly to arterial hypertension, and the most important risks
include development of pre-eclampsia, exacerbation of chronic
hypertension, heart failure, and cerebral vascular accidents.8
B
Fig. 2. Post-contrast CT images (A) in the axial post-contrast venous phase and (B) coronal curved reconstruction in the arterial
phase demonstrating marked thickening of the wall of the thoracic aorta (arrows). Note the involvement of the thoracic aorta
only, with sparing of the abdominal aorta.
e16
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 26, No 1, January/February 2015
Low-dose aspirin for pre-eclampsia prevention should be started
before 16 weeks.
Lakhi and Jones reported a case of Takayasu arteritis
complicated by aortic dissection in the peripartum period.8
In this report, the patient’s blood pressure remained elevated
(160/91 mmHg) when she became symptomatic on the third
postpartum day. In the 2003–2005 Confidential Enquiries into
Maternal Deaths in the United Kingdom, aortic dissection
was one of the leading causes of maternal death.9 The deaths
occurred mostly from failure to treat systolic hypertension.
Foetal complications such as growth restriction, miscarriage and
foetal death have been reported in 60–90% of cases.10 Foetal growth
restriction is most likely the result of impaired placental blood flow
caused by uncontrolled blood pressure and the involvement of the
abdominal aorta and renal arteries. Another mechanism could
be occlusion of the renal arteries, leading to an increase in renin
production, with consequent increase in blood pressure.11
The mode of delivery is determined by the maternal
haemodynamic status and by obstetric indications. Unfortunately
there are very little data to guide clinicians as to the optimal mode
of delivery. Labour and vaginal delivery with or without epidural
anaesthesia is safe provided blood pressure is controlled.8
Patients with Takayasu disease experience a severe elevation of
systolic blood pressure during uterine contractions, compared
to control patients, so regular monitoring of blood pressure is
important during labour.12 The second stage of labour should be
shortened by the use of low forceps or vacuum delivery.
Leal et al. recommend vaginal delivery for patients in groups
I and IIa, as long as epidural analgesia is used for pain relief
and the second stage of labour shortened by vacuum or forceps.5
Caesarean section is recommended for patients in group IIb and III
because the increased blood volume and blood pressure observed
during uterine contractions may lead to cardiac decompensation.5
Regional anaesthesia has been reported successfully for caesarean
delivery.13 This method also allows monitoring of brain perfusion
through the patient’s level of consciousness. Our patient had an
elective caesarean section because, although the blood pressure
was controlled, her aorta was severely dilated. This put her at a
significant risk of dissection or rupture of the aorta.
Patients should be nursed in a high-care unit postoperatively
to allow for early detection of hypoperfusion of organs
and hypertensive complications. After delivery, maternal
peripheral resistance and left ventricular workload increases.
This physiological change may lead to the development of
pulmonary oedema, heart failure, renal dysfunction or cerebral
haemorrhage.14 Use of immunosuppressive treatment may also
increase the risk of puerperal infection.
AFRICA
Conclusion
Patients with Takayasu disease in pregnancy are at risk of
several obstetric complications. These patients should be jointly
managed during pregnancy by obstetricians, rheumatologists
and cardiologists. Systemic hypertension must be aggressively
treated to reduce the risk of complications.
References
1.
Sadura E, Jawniak R, Majewski M, Czekajska-Chehab E. Takayasu
arteritis as a cause of arterial hypertension. Case report and literature
review. Eur J Pediatr 2012; 171: 863–869.
2.
Mason JC. Takayasu arteritis-advances in diagnosis and management.
3.
Hahn D, Thomson PD, Kala U, Beale PG, Levin SE. A review of
Nature Rev Rheumatol 2010; 6: 406–415.
Takayasu’s arteritis in children in Gauteng, South Africa. Pediatr nephrol 1998; 12: 668–678.
4.
Dabague AL, Reyes PA. Takayasu’s arteritis in Mexico: a 38 year clinical perpective through literature review. Int J Cardiol 1996; 54: 103–109.
5.
Leal PdC, Silveira FFM, Sadatsune EJ, Clivatti J, Yamashita AM.
Takayasus’s arteritis in pregnancy. Case report and literature review. Rev
Bras Anesttesiol 2011; 61: 479–485.
6.
Ishikawa K. Natural history and classification of occlusive thromboaortopathy. Circulation 1978; 57: 25–35.
7.
Mandal D, Mandal S, Dattaray C, et al. Takayasu arteritis in pregnancy:
8.
Lakhi NA, Jones J. Takayasu’s arteritis in pregnancy complicated by
an analysis from eastern India. Arch Gynecol Obstet 2011; 285: 567–571.
peripartum aortic dissection. Arch Gynecol Obstet 2010; 282: 103–106.
9.
Nelson-Piercy C. Saving mother’s lives. The seventh report of the
confidential enquiries into maternal deaths in the United Kingdom
2003–2005. London: RCOG Press, 2007.
10.
Matsumura A, Moriwaki R, Numano F. Pregnancy in Takayasu arteritis from the view of internal medicine. Heart Vessels 1992; 7: 120–124.
11.
Suri V, Aggarwal N, Keepanasseril A, Chopra S, et al. Pregnancy and
Takayasu arteritis: a single centre experience from North India. J Obstet
Gynaecol Res 2010; 36: 519–524.
12.
Ishikawa K, Matsuura S. Occlusive thromboaortopathy (Takayasu’s
disease) and pregnancy. Clinical course and management of 33 pregnancies and deliveries. Am J Cardiol 1982; 50: 1293–1300.
13.
Williams GM, Gott VL, Brawley RK, Schauble JF, Labs JD. Aortic
disease associated with pregnancy. J Vasc Surg 1988; 8: 470–475.
14.
Cunningham FG, Pritchard JA, Hankins GD, et al. Peripartum heart
failure: idiopathic cardiomyopathy or compounding cardiovascular
events? Obstet Gynecol 1986; 67: 157–168.